Loan & DebtJun 23, 2026, 04:07 PM
Nyxoah Secures $15M EIB Loan, Total June Capital Raised $110M
AI Summary
Nyxoah SA announced it received $15 million from the European Investment Bank, completing a total of $110 million in new capital raised in June 2026, including a recent equity offering. This non-dilutive debt funding will accelerate the US commercial launch of its Genio system, support R&D, and scale up manufacturing. Additionally, the company scheduled an extraordinary shareholders' meeting for July 9, 2026, to renew its authorized capital, and disclosed several transparency notifications regarding changes in major shareholdings.
Key Highlights
- Nyxoah received $15 million (€13.8 million) from the European Investment Bank (EIB).
- This non-dilutive debt funding brings the total capital raised in June 2026 to $110 million.
- Proceeds are intended to accelerate the commercial launch of Genio in the United States.
- Funds will also support continued investment in research and development and manufacturing scale-up.
- An extraordinary shareholders' meeting is scheduled for July 9, 2026, to renew authorized capital.
- Robert Taub's voting rights increased to 14.45% (plus 0.05% in financial instruments) as of June 10, 2026.
- Cochlear Limited's voting rights decreased to 5.85% due to a passive crossing of the 10% threshold.
- Bank of America Corporation's total voting rights (including financial instruments) decreased to 2.82%.
Price Impact
More from NYXH